Home › Trial NCT01383538
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
- Trial IDNCT01383538
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorAndrew Ko
- Enrollment15
- Start date2011-08-23
- ConditionsPancreatic Cancer · Adenocarcinoma · Pancreatic Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.